More recent acquisitions in 2024—oncology firms Mirati and RayzeBio and neurology firm Karuna—also help support Bristol's strong overall pipeline and wide moat. Bristol has created a strong pipeline ...

Bristol Myers Squibb Co. raised its 2024 earnings guidance after reporting better-than-expected revenue and profit, fueled by demand for the blood-thinner Eliquis and several newer treatments.Adjusted ...

The company reported $11.9B in revenue for the quarter with ~8% YoY growth as its blockbuster drugs Revlimid and Eliquis surpassed expectations, while sales from cancer therapy Opdivo slightly ...

Bristol-Myers Squibb Co.’s stock rose 2.9% early Thursday, after the drug company posted better-than-expected third-quarter earnings and raised its guidance. Princeton, N.J.-based Bristol Myers had ...

U.S. Treasury bond yields rose as traders reviewed the gross domestic product reading for the third quarter and looked ahead to key inflation data out later in the session. The 10-year Treasury yield ...

Eliquis sales reached $3 billion from $2.71 billion a year ago. The company reported an adjusted EPS of $1.80, compared to an income of $2.00 a year ago, beating the consensus of $1.49. With cost ...

This saves considerable overhead and simplifies the process, but it also means that Tesla sits on inventory instead of passing that cost along to franchise dealers. Even with economies of scale ...

The Biden Administration made significant strides, notably capping insulin prices at $35 per month as part of the 2023 Inflation Reduction Act (IRA). This mandatory cap delivers savings to ...

The team would rather that $700 difference goes into its pocket, not yours. Resale prices for the World Series between the Dodgers and New York Yankees at Dodger Stadium have soared, with prices ...